Janet Tate Selected Research

Acquired Immunodeficiency Syndrome (AIDS)

1/2019	Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals.
1/2018	Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological Conditions.
11/2017	Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older.
10/2016	Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals.
4/2015	Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.
8/2012	The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Janet Tate Research Topics

Disease

6	Acquired Immunodeficiency Syndrome (AIDS) 01/2019 - 08/2012
2	Herpes Zoster 08/2021 - 12/2018
2	Progressive Multifocal Leukoencephalopathy 08/2021 - 07/2014
2	Toxoplasmosis 08/2021 - 07/2014
2	AIDS Dementia Complex 01/2018 - 07/2014
1	Delirium 01/2023
1	COVID-19 01/2022
1	Marijuana Use 09/2021
1	Bacteremia 08/2021
1	Tuberculosis (Tuberculoses) 08/2021
1	Esophagitis 08/2021
1	Coccidioidomycosis 08/2021
1	Cryptococcosis 08/2021
1	Nontuberculous Mycobacterium Infections 08/2021
1	Neoplasms (Cancer) 08/2021
1	Opportunistic Infections (Opportunistic Infection) 08/2021
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 08/2021
1	Histoplasmosis 08/2021
1	Heart Failure 01/2021
1	Pain (Aches) 11/2020
1	Dyspnea (Shortness of Breath) 04/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2019
1	Kidney Diseases (Kidney Disease) 01/2019
1	Proteinuria 01/2019
1	Substance-Related Disorders (Drug Abuse) 07/2017
1	Viremia 12/2016
1	Weight Gain 06/2015
1	Cryptococcal Meningitis 07/2014
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2013
1	Hepatitis C 05/2013
1	Anemia 11/2011

Drug/Important Bio-Agent (IBA)

3	efavirenz (Sustiva)FDA Link 01/2018 - 08/2012
3	Atazanavir Sulfate (Reyataz)FDA Link 01/2018 - 04/2015
3	Hemoglobins (Hemoglobin)IBA 06/2015 - 11/2011
2	Opioid Analgesics (Opioids)IBA 09/2021 - 07/2017
2	RNA (Ribonucleic Acid)IBA 01/2019 - 05/2013
2	Lopinavir FDA Link 01/2018 - 04/2015
1	ORALIT (ORS)IBA 01/2023
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2023
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Crack CocaineIBA 09/2021
1	insulin receptor-related receptor (IRR)IBA 08/2021
1	Cocaine (Cocaine HCl)IBA 11/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2020
1	Histone Deacetylase 1IBA 01/2019
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2019
1	Histone Deacetylase InhibitorsIBA 01/2019
1	VaccinesIBA 12/2018
1	Herpes Zoster VaccineIBA 12/2018
1	Darunavir (Prezista)FDA Link 01/2018
1	Heroin (Diamorphine)IBA 07/2017
1	Proton Pump InhibitorsIBA 05/2013
1	Protease Inhibitors (Protease Inhibitor)IBA 05/2013
1	Nevirapine (Viramune)FDA Link 08/2012
1	NucleosidesIBA 08/2012
1	Reverse Transcriptase InhibitorsIBA 08/2012
1	LeptinIBA 11/2011

Therapy/Procedure

7	Therapeutics 01/2018 - 11/2011
1	Drug Therapy (Chemotherapy) 08/2021
1	Terminal Care (Care, Terminal) 01/2021
1	Polypharmacy 04/2020
1	Highly Active Antiretroviral Therapy (HAART) 12/2018
1	Ambulatory Care (Outpatient Care) 12/2016
1	Art Therapy 06/2015